Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: AstraZeneca
July 19, 2012
Loss of exclusivity for key brands wallops results   Read More »
Financial Report: Novartis
July 19, 2012
Currency impacts results   Read More »
Financial Report: Abbott
July 18, 2012
Humira sales up 8%   Read More »
Financial Report: Johnson & Johnson
July 18, 2012
Earnings drop 49% in the quarter   Read More »
Financial Report: Patheon 2Q12
June 13, 2012
CMO revenues up 6% in the quarter   Read More »
Financial Report: Alkermes
May 17, 2012
EDT merger boosts revenues   Read More »
Financial Report: WuXi PharmaTech
May 11, 2012
Revenues climb 26% in the quarter   Read More »
Financial Report: BASi
May 11, 2012
Revenues down 17%   Read More »
Financial Report: AMRI 1Q12
May 9, 2012
Hungary closure leads to charges   Read More »
Financial Report: Teva
May 9, 2012
Cephalon product sales boost results   Read More »
Financial Report: BioClinica
May 9, 2012
Backlog hits record $125.8 million   Read More »
Financial Reports: Jubilant LifeSciences FY12
May 7, 2012
Jubilant LifeSciences 4Q Revenues: $216.2 million 4Q Loss: $11.7 million FY Revenues: $786.7 million FY Earnings: $2.8 million Comments: CMO operations, including the Jubilant HollisterStier operations, were up 17% year-on-year to $114 million i…   Read More »
Financial Reports: Covance 1Q
May 3, 2012
Early Development slowdown leads to restructuring   Read More »
Financial Reports: Charles River 1Q
May 3, 2012
Preclinical revenues drop, offset by RMS uptick   Read More »
Financial Report: Parexel 3Q
May 1, 2012
Backlog grows, but ramping up for new business leads to tighter margins   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: